Evidence map›Paper›PMID 40128339›Full record

ArticleEuropean journal of human genetics : EJHG2025

Novel variants in FOXI3 gene confirm its implication in Oculo-Auriculo-Vertebral spectrum.

Angèle Sequeira, Thomas Sagardoy, Laetitia Bourgeade, Didier Lacombe, Elizabeth Sarrazin, Annick Toutain, Caroline Rooryck

Abstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Angèle SequeiraUniv. Bordeaux, INSERM, MRGM, U1211, Bordeaux, France. angela.sequeira@u-bordeaux.fr.ORCID 0000-0003-1103-2158
Thomas SagardoyUniv. Bordeaux, INSERM, MRGM, U1211, Bordeaux, France.
Laetitia BourgeadeCHU de Bordeaux, Service de Génétique Médicale, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Bordeaux, France.
Didier LacombeUniv. Bordeaux, INSERM, MRGM, U1211, Bordeaux, France.
Elizabeth SarrazinCentre de Référence Caribéen de Maladies Neuromusculaires Rares, CERCA, CHU de Martinique, Fort de France, France - Centre de Référence des Neuropathies Amyloïdes familiales et autres Neuropathies Périphériques Rares (NNERF), Service de Cardiologie, CHU de Martinique, Fort de France, France.
Annick ToutainDepartment of Medical Genetics, Centre Hospitalier Universitaire, Tours, France.
Caroline RooryckUniv. Bordeaux, INSERM, MRGM, U1211, Bordeaux, France.ORCID 0000-0002-9789-3591

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular bases of the clinically heterogenous Oculo-Auriculo-Vertebral Spectrum or Craniofacial Microsomia remain largely unknown. Although genetic diagnosis is established in less than 10% of the patients, variants in the FOXI3 gene are the most recurrent genetic cause. We studied a large family with 6 affected individuals on 4 generations showing an autosomal dominant transmission of Oculo-Auriculo-Vertebral Spectrum with incomplete penetrance. The genome sequencing strategy allowed the identification of a new likely pathogenic missense variant located within the Nuclear Localization Signal of FOXI3 and affecting its subcellular localization. Moreover, we described 3 additional rare FOXI3 variants identified in 3 other patients from a cohort of 251 patients with Oculo-Auriculo-Vertebral Spectrum. These variants were classified as Variants of Unknown Significance. In conclusion, this study confirms FOXI3 implication in the Oculo-Auriculo-Vertebral Spectrum and the importance of Nuclear Localization Signal integrity. Genotype-phenotype correlations and putative modifier haplotype are discussed.

Indexed as

Goldenhar SyndromeMutation, MissenseAdultFemaleHumansMalePedigree

Identifiers

PMID40128339
PMCPMC12048623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.